Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Psychopharmacology (Berl) ; 239(7): 2155-2169, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35348805

ABSTRACT

Deficits in early auditory sensory processing in schizophrenia have been linked to N-methyl-D-aspartate receptor (NMDAR) hypofunction, but the role of NMDARs in aberrant auditory sensory gating (SG) in this disorder is unclear. This study, conducted in 22 healthy humans, examined the acute effects of a subanesthetic dose of the NMDAR antagonist ketamine on SG as measured electrophysiologically by suppression of the P50 event-related potential (ERP) to the second (S2) relative to the first (S1) of two closely paired (500 ms) identical speech stimuli. Ketamine induced impairment in SG indices at sensor (scalp)-level and at source-level in the auditory cortex (as assessed with eLORETA). Together with preliminary evidence of modest positive associations between impaired gating and dissociative symptoms elicited by ketamine, tentatively support a model of NMDAR hypofunction underlying disturbances in auditory SG in schizophrenia.


Subject(s)
Auditory Cortex , Ketamine , Acoustic Stimulation , Electroencephalography , Evoked Potentials, Auditory , Humans , Ketamine/pharmacology , Receptors, N-Methyl-D-Aspartate , Sensory Gating , Speech
2.
Pharmacol Biochem Behav ; 211: 173287, 2021 12.
Article in English | MEDLINE | ID: mdl-34653398

ABSTRACT

Impairments in auditory information processing in schizophrenia as indexed electrophysiologically by P300 deficits during novelty (P3a) and target (P3b) processing are linked to N -methyl- D -aspartate receptor (NMDAR) dysfunction. This study in 14 healthy volunteers examined the effects of a subanesthetic dose of the NMDAR antagonist ketamine on P300 and their relationship to psychomimetic symptoms and cortical source activity (with eLORETA). Ketamine reduced early (e- P3a) and late (l-P3a) novelty P300 at sensor (scalp)-level and at source-level in the salience network. Increases in dissociation symptoms were negatively correlated with ketamine-induced P3b changes, at sensor-level and source-level, in both salience and central executive networks. These P3a alterations during novelty processing, and the symptom-related P3b changes during target processing support a model of NMDAR hypofunction underlying disrupted auditory attention in schizophrenia.


Subject(s)
Event-Related Potentials, P300 , Ketamine/therapeutic use , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Schizophrenia/physiopathology , Acoustic Stimulation/methods , Adult , Attention , Auditory Perception , Cognition , Double-Blind Method , Electroencephalography/methods , Healthy Volunteers , Humans , Male , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL